Pune, India -- (SBWIRE) -- 03/25/2019 -- The global Womens Wealth Market was sized near USD 43.52 billion in 2016. The global womens health market is projected to grow with a CAGR of 5.72% during 2018-2024. Health defined by the World Health Organization as a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. Women health refers to the health of the womens which is an example of population health. Womens health is influenced not just by their biology but also by conditions such as employment, poverty and family responsibilities.

Womens Health Market: Insight

Women's experience of health and disease differ from those of men, due to unique biological, social and behavioral conditions. Moreover, sexually transmitted infections have serious consequences for womens and infants. In addition, infertility from many other causes, birth control, unplanned pregnancy, unconsensual sexual activity and the struggle for access to abortion create other burdens for women.

A woman has unique health issues such as pregnancy, menopause, and other diseases. The innovations in prescription drugs for women health are used to treat a number of diseases and conditions in a variety of therapeutic areas. According to eHealthMe, about 52.3% of women in the age of 50 to 59 suffer from menopause uses antidepressant therapy.

Womens Health Market: Drivers and Restraints

The Growing female elderly population, unhealthy lifestyle, satisfactory government strategies & initiatives by private organizations are some of the drivers that boost the market. Research and development for innovation of new medicines for women are likely to surge this market. Additionally, increasing awareness among society about the availability of treatment for women's health-related diseases propel the growth of this market. Moreover, improving healthcare organization in emerging markets and the rising number of government approvals for immunoassay techniques provide substantial growth opportunities for key players in the women health market.

Download Exclusive Sample Copy of Report: https://www.infiniumglobalresearch.com/reports/sample-request/1142

Womens Health Market: Segmentation

Among treatment type non-hormonal segment is considered to be the largest market for the women's health market. New cultured treatments with specific mechanism are being introduced which results in high investments. Due to the growing adoption of these products and new developments are driving the demand for the non-hormonal segment. Also, due to the risk of breast cancer, the use of hormonal products has been reduced which has boosted the demand for non-hormonal pharmaceutical products. Moreover, the Asia Pacific market is anticipated to grow with the highest CAGR during the forecast period.

Womens Health Market: Competitive Landscape

The report provides profiles of the companies in the global women's health market such as Novartis AG, Merck & Co., Inc., Amgen Inc, Eli Lilly and Company, Lupin Pharmaceuticals, Inc., Novo Nordisk A/S, AstraZeneca, Pfizer, Inc., Sanofi and Other. This industry feature for merger and acquis ion as an explanations strategy for instance Ahmedabad-based Torrent Pharma has completed the acquisition of women healthcare brands Ragstone and Precative for India from Swiss pharma major Novartis AG.

Browse Detailed TOC and Description of this Exclusive Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-womens-health-market

Reasons to Buy this Report:

- Comprehensive analysis of global as well as regional markets of the Women's Health.

- Complete coverage of all the product type and applications segments to analyze the trends,
developments, and forecast of market size up to 2024.

- Comprehensive analysis of the companies operating in this market. The company profile includes analysis
of product portfolio, revenue, SWOT analysis and the latest developments of the company.

- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies
that market players should focus to invest, consolidate, expand and/or diversify.